| Dr Robert Emmett Smith, DDS | |
|
3610 W Market St, Fairlawn, OH 44333-9301 | |
| (330) 666-7800 | |
| (330) 665-1753 |
| Full Name | Dr Robert Emmett Smith |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 3610 W Market St, Fairlawn, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316960685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 30-016834 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Emmett Smith, DDS 3610 W Market St, Fairlawn, OH 44333-9301 Ph: (330) 666-7800 | Dr Robert Emmett Smith, DDS 3610 W Market St, Fairlawn, OH 44333-9301 Ph: (330) 666-7800 |
News Archive
Mild cognitive impairment is often seen as a transition stage between the cognitive decline of normal aging and the more serious problems of Alzheimer's disease. But what leads to mild cognitive impairment?
Fibrocell Science, Inc. announced today that the U.S. Food and Drug Administration's (FDA) Cellular, Tissue and Gene Therapies Advisory Committee reviewed azfibrocel-T, an autologous cell therapy being investigated for the treatment of moderate to severe nasolabial fold wrinkles in adults.
Women who gave birth during the COVID-19 pandemic report having felt greater stress in the delivery process, and rate lower the quality of care received.
The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.
› Verified 3 days ago
Dr. Michael Alan Blum, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 55 S Miller Rd, Suite 102, Fairlawn, OH 44333 Phone: 330-836-8050 Fax: 330-836-8210 | |
Dr. Glenn Boris Shtarkman, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 620 Ridgewood Xing, Fairlawn, OH 44333 Phone: 330-733-7911 Fax: 330-733-7911 | |
Ayah Koleilat, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3523 Commercial Dr, Fairlawn, OH 44333 Phone: 330-668-9977 | |
Donald Douglas Mackay, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 33 Merz Blvd, Fairlawn, OH 44333 Phone: 330-864-8822 Fax: 330-864-1957 | |
Dr. Dyren Brown, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3737 W Market St, Fairlawn, OH 44333 Phone: 330-668-8880 | |
Dr. Mark C Gorman, DDS Dentist Medicare: Medicare Enrolled Practice Location: 3045 Smith Road, Suite 600, Fairlawn, OH 44333 Phone: 330-668-4044 Fax: 330-668-4054 | |
Dr. Maria Haas, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3500 W Market St, Fairlawn, OH 44333 Phone: 330-666-6541 |